Latest news
CSL Plans Pediatric ANDEMBRY Filing After Phase 3b Data - MyChesCoMyChesCo · Thu, 06 Aug 2026 15:15:00 GMTCSL (ASX:CSL) Following ANDEMBRY Trial Results Still Looks Cheap Against Fair Value - simplywall.stsimplywall.st · Sat, 01 Aug 2026 17:55:03 GMTCSL eyes Andembry spot on paediatric HAE market amid positive Phase III results - Clinical Trials ArenaClinical Trials Arena · Tue, 28 Jul 2026 10:32:49 GMT